At 42, can new therapies for my RA reduce infection risk?

Question

Hello doctor,

I am a 42-year-old with rheumatoid arthritis (RA) for six years, progressing rapidly despite trying multiple medications and treatments. My hands are so deformed that I can not open jars, type, or button my own clothes anymore. Morning stiffness lasts three to four hours, and constant pain despite prescription medicines.

I have tried Methotrexate, Sulfasalazine, and two biologics, but they stop working or cause terrible infections. The latest biologic caused severe fatigue, and I got pneumonia twice in six months.

The rheumatologist wants another TNF (tumor necrosis factor) inhibitor, but I am scared about more immune suppression after infections. X-rays show joint erosion in hands and feet, which terrifies me. Work as a hairstylist is becoming impossible, and fatigue is overwhelming. I need inflammation control that does not make me sick.

Please tell me, are there newer targeted therapies working better without constant infection risk?

Kindly help.

Answer 1

Hello,

Welcome to icliniq.com.

I read your query and can understand your concern.

Rheumatoid arthritis (RA) can be exhausting not just physically, but emotionally, too. When your hands and feet start showing erosions, and your work becomes harder. It is completely understandable to feel scared and frustrated. You deserve a treatment plan that controls your inflammation without making you feel constantly vulnerable to infections.

There are options now that focus more precisely on the overactive pathways in RA, and many patients tolerate them much better. They do not wipe out the whole immune system; instead, they block very specific signals.

JAK (Janus kinase) Inhibitors (Oral tablets) like Tofacitinib, Baricitinib, and Upadacitinib are pills, not injections. They target the inside signalling of immune cells, so the effect is very directed. Many patients feel a quicker drop in pain, stiffness, and fatigue. Infection risk is still there, but often less severe compared to older biologics. This is a good option for people who cannot tolerate Methotrexate or injections.
IL-6 (interleukins) inhibitors such as Tocilizumab and Sarilumab block IL-6, one of the strongest inflammation drivers in RA. People often report less fatigue and better energy because IL-6 is linked to tiredness. Infection risk exists, but not everyone gets recurrent infections.
Abatacept (T-cell targeted therapy) is one of the biologics. It works by upstream on T-cells, so immunity is not completely suppressed. It is often preferred in patients who get frequent infections on other drugs.

I hope this information helps you.

Please feel free to reach out in case of further queries.

Thank you.